Key Points
Increased IL-36 levels were found in Con A–injected mice.
Deficiency of IL-36R led to exacerbated liver injury and increased mortality.
A lack of IL-36 signaling exaggerated T cell responses and inflammation in the liver.
Abstract
The IL-36 family, including IL-36α, IL-36β, IL-36γ, and IL-36R antagonist, belong to the IL-1 superfamily. It was reported that IL-36 plays a role in immune diseases. However, it remains unclear how IL-36 regulates inflammation. To determine the role of IL-36/IL-36R signaling pathways, we established an acute hepatitis mouse model (C57BL/6) by i.v. injection of the plant lectin Con A. We found that the levels of IL-36 were increased in the liver after Con A injection. Our results demonstrated the infiltrated neutrophils, but not the hepatocytes, were the main source of IL-36 in the liver. Using the IL-36R−/− mouse model (H-2b), we surprisingly found that the absence of IL-36 signals led to aggravated liver injury, as evidenced by increased mortality, elevated serum alanine aminotransferase and aspartate aminotransferase levels, and severe liver pathological changes. Further investigations demonstrated that a lack of IL-36 signaling induced intrahepatic activation of CD4+ and CD8+ T lymphocytes and increased the production of inflammatory cytokines. In addition, IL-36R−/− mice had reduced T regulatory cell numbers and chemokines in the liver. Together, our results from the mouse model suggested a vital role of IL-36 in regulating T cell function and homeostasis during liver inflammation.
Footnotes
This work was supported by grants from the National Natural Science Foundation of China (81800506), the Natural Science Foundation of Hunan Province China (2019JJ40494 to P.Y.), the U.S. Department of Health and Human Services (HHS)/National Institute of Health (NIH)/National Eye Institute (EY028773 to J.C. and J.S.), and the HHS/NIH/National Institute of Allergy and Infectious Diseases (I132674 to L.S. and AI153586 to Y.L.), and a University of Texas Medical Branch Institute of Human Infections and Immunity pilot grant (to L.S. and Y.L.).
The online version of this article contains supplemental material.
- Received May 21, 2021.
- Accepted December 7, 2021.
- Copyright © 2022 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.